Julian is the Group Vice President and head of Development Operations and Project Management at the Incyte Corporation in Wilmington, Delaware. His team are accountable for the strategy, planning and execution of Incyte’s oncology, inflammation and autoimmunity clinical development portfolio. He has almost 30 years’ experience in the life science and pharmaceutical industry, including a variety of scientific, business and operational leadership roles at Incyte and GlaxoSmithKline, and a number of years as a leader on the TransCelerate Biopharma oversight committee. Julian is an adjunct professor in drug development and business administration at the University of the Sciences in Philadelphia, and has published and presented research in the areas of virology, hematology and clinical trial technologies. He is a proud husband and father of four children and a rescued dog. Julian grew up in the Welsh valleys and received his PhD from the University of Nottingham Medical School in the UK.